By proceeding, you agree to our Terms of Use and Privacy Policy.
The European Society for Translational Medicine (EUSTM) cordially invites you to attend the 9th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care (EUSTM-2022) held in virtual format during 3-5 October, 2022.
Exchange, discuss and network with key stakeholders in academic research, clinical care, and public health.
The Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders & more.
Professors from Harvard Medical School & more will discuss a practical approach to selection of first-line treatment for metastatic urothelial cancer.
The event provides a platform for scientific exchange and discussion about the recent progress in immunotherapies for cancer and infectious diseases.
15-17 April 2024
Join us at the Festival of Biologics USA 2024, the most exciting biologics event in America! Taking place from April 15 to 17, 2024, at the renowned San Diego Convention Center, this three-day event will cover the entire journey of biologic drug deve
Starts in 17 days
USA
Paid
San Diego
18-19 April 2024
Join us at the MarketsandMarkets High Potent Medicines Conference, taking place on 19th - 20th October 2023, in Boston, USA. This groundbreaking conference is designed to address the emerging trends and challenges in the high potent medicines market.
Starts in 20 days
Boston
The European Society for Translational Medicine (EUSTM) is a global non-profit neutral platform for the advancement and progress of Translational Medicine by offering high quality educational programs and events.
Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.